Skip to main content
Top

Journal of Cachexia, Sarcopenia and Muscle

Issue 2/2011

Content (8 Articles)

Open Access Editorial

Pitfalls in defining and quantifying cachexia

Vickie E. Baracos

Open Access Review

Clinical use of amino acids as dietary supplement: pros and cons

Francesco S. Dioguardi

Open Access Original Article

Body mass index and prognosis in patients hospitalized with acute exacerbation of chronic obstructive pulmonary disease

Mitja Lainscak, Stephan von Haehling, Wolfram Doehner, Irena Sarc, Tina Jeric, Kristina Ziherl, Mitja Kosnik, Stefan D. Anker, Stanislav Suskovic

Open Access Original Article

The cachexia score (CASCO): a new tool for staging cachectic cancer patients

Josep M. Argilés, Francisco J. López-Soriano, Míriam Toledo, Angelica Betancourt, Roberto Serpe, Sílvia Busquets

Open Access Original Article

Combined approach to counteract experimental cancer cachexia: eicosapentaenoic acid and training exercise

Fabio Penna, Silvia Busquets, Fabrizio Pin, Miriam Toledo, Francesco M. Baccino, Francisco J. López-Soriano, Paola Costelli, Josep M. Argilés

Open Access Original Article

IGF-1 treatment reduces weight loss and improves outcome in a rat model of cancer cachexia

Katja Schmidt, Stephan von Haehling, Wolfram Doehner, Sandra Palus, Stefan D. Anker, Jochen Springer

Open Access Original Article

Intramyocellular lipid droplets increase with progression of cachexia in cancer patients

Nathan A. Stephens, Richard J. E. Skipworth, Alisdair J. MacDonald, Carolyn A. Greig, James A. Ross, Kenneth C. H. Fearon

Open Access Erratum

Erratum to: Wasting in chronic kidney disease

Robert H. Mak, T. Alp Ikizler, Csaba P. Kovesdy, Dominic S. Raj, Peter Stenvinkel, Kamyar Kalantar-Zadeh

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine